Index S&P 500
P/E 85.40
EPS (ttm) 3.42
Insider Own 5.32%
Shs Outstand 75.30M
Perf Week 4.22%
Market Cap 22.06B
Forward P/E 51.05
EPS next Y 5.73
Insider Trans -3.39%
Shs Float 71.45M
Perf Month -0.55%
Income 262.31M
PEG 4.69
EPS next Q 1.02
Inst Own 79.82%
Short Float 3.62%
Perf Quarter -4.98%
Sales 1.68B
P/S 13.12
EPS this Y 9.10%
Inst Trans 2.57%
Short Ratio 5.11
Perf Half Y 17.85%
Book/sh 24.09
P/B 12.13
EPS next Y 26.77%
ROA 7.92%
Short Interest 2.59M
Perf Year 47.78%
Cash/sh 14.12
P/C 20.70
EPS next 5Y 18.20%
ROE 16.29%
52W Range 175.37 - 329.87
Perf YTD 13.16%
Dividend Est. -
P/FCF 135.91
EPS past 5Y 35.57%
ROI 10.37%
52W High -11.38%
Beta 0.95
Dividend TTM -
Quick Ratio 2.55
Sales past 5Y 30.13%
Gross Margin 60.16%
52W Low 66.70%
ATR (14) 6.64
Dividend Ex-Date -
Current Ratio 2.91
EPS Y/Y TTM 81.99%
Oper. Margin 9.19%
RSI (14) 52.19
Volatility 2.19% 2.16%
Employees 3330
Debt/Eq 0.39
Sales Y/Y TTM 31.69%
Profit Margin 15.60%
Recom 1.38
Target Price 367.27
Option/Short Yes / Yes
LT Debt/Eq 0.39
EPS Q/Q 182.67%
Payout 0.00%
Rel Volume 0.79
Prev Close 293.48
Sales Surprise 4.34%
EPS Surprise 21.63%
Sales Q/Q 34.31%
Earnings May 06 AMC
Avg Volume 507.29K
Price 292.33
SMA20 2.50%
SMA50 -2.11%
SMA200 12.99%
Trades
Volume 399,645
Change -0.39%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-10-24 Reiterated
Needham
Buy
$315 → $400
Mar-13-24 Initiated
Argus
Buy
$380
Aug-22-23 Initiated
Morgan Stanley
Equal-Weight
$230
Jul-05-23 Resumed
JP Morgan
Overweight
$236
May-11-23 Upgrade
JP Morgan
Neutral → Overweight
$236
Mar-08-23 Initiated
Goldman
Buy
$263
Mar-02-23 Downgrade
JP Morgan
Overweight → Neutral
$224
Feb-17-23 Downgrade
Raymond James
Strong Buy → Outperform
$223
Sep-15-22 Initiated
Barclays
Overweight
$147
May-23-22 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$120
May-10-22 Initiated
Credit Suisse
Outperform
$169
Feb-25-22 Upgrade
JP Morgan
Neutral → Overweight
$222 → $192
Dec-14-21 Resumed
JMP Securities
Mkt Outperform
$195
Nov-16-21 Upgrade
Craig Hallum
Hold → Buy
$232
May-19-21 Upgrade
Raymond James
Mkt Perform → Strong Buy
$150
Feb-12-21 Downgrade
JP Morgan
Overweight → Neutral
$129 → $179
Show Previous Ratings
Jun-12-24 06:17AM
Jun-11-24 09:30AM
Jun-10-24 01:57PM
Jun-05-24 11:30AM
09:00AM
03:08AM
Loading…
Jun-04-24 03:08AM
May-29-24 07:00PM
10:52AM
07:00AM
May-24-24 11:45AM
May-21-24 07:00PM
05:24AM
May-20-24 01:54PM
May-16-24 09:00AM
May-15-24 06:00AM
07:00AM
Loading…
May-09-24 07:00AM
May-08-24 09:30AM
01:01AM
May-07-24 04:16PM
12:09PM
10:58AM
08:05AM
(Investor's Business Daily)
03:13AM
May-06-24 06:00PM
05:42PM
05:33PM
05:17PM
(Investor's Business Daily)
04:35PM
04:11PM
(Associated Press Finance)
04:02PM
04:01PM
Loading…
04:01PM
10:38AM
(Investor's Business Daily)
May-03-24 08:38AM
May-01-24 09:15AM
Apr-29-24 06:00PM
10:00AM
Apr-28-24 09:20AM
Apr-26-24 09:30AM
Apr-25-24 09:00AM
Apr-23-24 09:30AM
Apr-22-24 06:00PM
04:01PM
Apr-19-24 12:10PM
09:45AM
Apr-16-24 06:00PM
Apr-11-24 09:30AM
09:00AM
Apr-10-24 04:49PM
01:57PM
10:05AM
Apr-09-24 06:00PM
Apr-01-24 09:30AM
Mar-29-24 09:00AM
Mar-28-24 11:30AM
Mar-27-24 09:06AM
Mar-25-24 11:12PM
10:41PM
Mar-22-24 05:50PM
Mar-20-24 06:00PM
Mar-18-24 09:00AM
Mar-15-24 08:32AM
Mar-05-24 09:00AM
Mar-01-24 10:57AM
Feb-29-24 02:32PM
08:55AM
Feb-28-24 04:11PM
(Investor's Business Daily) +13.76%
02:37PM
02:00PM
12:50PM
(Associated Press Finance)
11:49AM
(Investor's Business Daily)
11:49AM
(Investor's Business Daily)
10:35AM
(Thomson Reuters StreetEvents)
05:52AM
Feb-27-24 06:00PM
05:02PM
04:42PM
04:12PM
(Associated Press Finance)
04:01PM
10:16AM
Feb-20-24 05:50PM
Feb-15-24 11:41AM
09:00AM
Feb-13-24 04:01PM
Feb-12-24 05:50PM
Feb-10-24 06:39AM
Feb-05-24 05:50PM
Feb-02-24 01:40PM
(Investor's Business Daily)
Feb-01-24 09:00AM
07:00AM
Jan-30-24 05:50PM
01:18PM
Jan-26-24 08:00AM
(Investor's Business Daily)
Jan-25-24 04:05PM
Jan-24-24 05:50PM
Jan-18-24 06:00PM
Jan-17-24 09:00AM
Jan-05-24 09:00AM
Jan-03-24 06:00PM
Jan-02-24 09:30AM
Dec-26-23 10:53AM
Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Cullivan Julie A Director May 31 '24 Sale 281.72 993 279,748 4,553 Jun 03 07:23 PM Cullivan Julie A Director May 28 '24 Sale 286.04 478 136,727 5,546 May 29 04:37 PM Kalinowski Caitlin Elizabeth Director May 20 '24 Sale 290.19 2,000 580,387 7,829 May 21 04:20 PM Isner Joshua PRESIDENT May 09 '24 Sale 309.96 44,000 13,638,357 275,843 May 13 05:45 PM Kunins Jeffrey C CPO & CTO May 09 '24 Sale 309.94 43,668 13,534,282 189,719 May 13 05:48 PM Williams Jeri Director May 09 '24 Sale 310.07 308 95,501 1,607 May 13 05:51 PM Isner Joshua PRESIDENT Jan 02 '24 Sale 251.68 35,400 8,909,327 309,564 Jan 04 04:36 PM Kunins Jeffrey C CPO & CTO Dec 19 '23 Sale 256.95 2,722 699,410 226,083 Dec 20 06:48 PM Isner Joshua PRESIDENT Dec 19 '23 Sale 257.13 2,562 658,778 344,964 Dec 20 06:46 PM Isner Joshua PRESIDENT Dec 18 '23 Sale 253.46 1,956 495,775 347,526 Dec 20 06:46 PM Kunins Jeffrey C CPO & CTO Dec 18 '23 Sale 253.46 1,796 455,218 228,805 Dec 20 06:48 PM Bagley Brittany COO & CFO Dec 14 '23 Sale 250.26 5,000 1,251,291 110,752 Dec 18 04:18 PM Isner Joshua PRESIDENT Dec 05 '23 Sale 233.59 3,653 853,313 349,482 Dec 05 06:32 PM Kunins Jeffrey C CPO & CTO Dec 05 '23 Sale 230.87 2,690 621,041 230,601 Dec 05 06:35 PM Kunins Jeffrey C CPO & CTO Dec 04 '23 Sale 230.79 2,729 629,838 233,291 Dec 05 06:35 PM Isner Joshua PRESIDENT Dec 04 '23 Sale 229.60 1,400 321,445 353,135 Dec 05 06:32 PM Kunins Jeffrey C CPO & CTO Dec 01 '23 Sale 230.38 635 146,289 236,020 Dec 05 06:35 PM Isner Joshua PRESIDENT Dec 01 '23 Sale 230.38 260 59,898 356,229 Dec 05 06:32 PM Bagley Brittany COO & CFO Nov 20 '23 Sale 225.61 5,000 1,128,050 115,752 Nov 21 04:37 PM Bagley Brittany COO & CFO Nov 17 '23 Sale 223.79 5,000 1,118,960 120,752 Nov 21 04:37 PM Kunins Jeffrey C CPO & CTO Nov 10 '23 Sale 217.33 41,167 8,946,820 236,655 Nov 13 04:41 PM Isner Joshua PRESIDENT Oct 02 '23 Sale 196.37 29,699 5,831,990 356,489 Oct 04 07:11 PM Cullivan Julie A Director Sep 11 '23 Sale 214.47 515 110,452 5,367 Sep 12 08:16 PM Isner Joshua PRESIDENT Jul 03 '23 Sale 193.10 26,883 5,191,179 290,965 Jul 05 06:14 PM Kunins Jeffrey C CPO & CTO Jul 03 '23 Sale 193.12 22,900 4,422,512 241,076 Jul 05 06:11 PM Partovi Hadi Director Jun 23 '23 Buy 191.10 25,000 4,777,388 413,817 Jun 26 03:03 PM Isner Joshua CHIEF OPERATING OFFICER Jun 16 '23 Sale 203.63 1,955 398,097 317,848 Jun 16 04:34 PM
Index RUT
P/E 37.01
EPS (ttm) 2.29
Insider Own 1.09%
Shs Outstand 50.79M
Perf Week -1.11%
Market Cap 4.31B
Forward P/E 15.58
EPS next Y 5.43
Insider Trans -5.42%
Shs Float 50.40M
Perf Month -12.26%
Income 117.56M
PEG 3.08
EPS next Q 1.01
Inst Own 101.09%
Short Float 6.48%
Perf Quarter 13.15%
Sales 1.31B
P/S 3.30
EPS this Y 16.06%
Inst Trans -0.60%
Short Ratio 5.88
Perf Half Y -3.78%
Book/sh 18.90
P/B 4.48
EPS next Y 18.22%
ROA 5.69%
Short Interest 3.26M
Perf Year 0.02%
Cash/sh 3.51
P/C 24.12
EPS next 5Y 12.00%
ROE 13.22%
52W Range 70.74 - 97.97
Perf YTD -0.99%
Dividend Est. 2.00 (2.36%)
P/FCF 37.36
EPS past 5Y 17.09%
ROI 6.48%
52W High -13.59%
Beta 0.30
Dividend TTM -
Quick Ratio 1.50
Sales past 5Y 6.80%
Gross Margin 51.41%
52W Low 19.68%
ATR (14) 2.52
Dividend Ex-Date -
Current Ratio 2.56
EPS Y/Y TTM 1.99%
Oper. Margin 15.63%
RSI (14) 41.26
Volatility 2.35% 2.74%
Employees 3657
Debt/Eq 0.91
Sales Y/Y TTM 12.01%
Profit Margin 8.98%
Recom 1.43
Target Price 113.29
Option/Short Yes / Yes
LT Debt/Eq 0.89
EPS Q/Q -30.93%
Payout 0.00%
Rel Volume 0.63
Prev Close 86.05
Sales Surprise 4.18%
EPS Surprise 0.92%
Sales Q/Q 12.77%
Earnings May 09 BMO
Avg Volume 555.10K
Price 84.66
SMA20 -4.19%
SMA50 -4.77%
SMA200 -0.38%
Trades
Volume 350,756
Change -1.62%
Date
Action
Analyst
Rating Change
Price Target Change
Jun-12-24 Upgrade
Needham
Hold → Buy
$112
Oct-13-22 Initiated
Mizuho
Buy
$90
Jan-27-22 Downgrade
Needham
Buy → Hold
Dec-15-21 Downgrade
Citigroup
Buy → Neutral
$75 → $59
Aug-17-21 Resumed
Raymond James
Outperform
$75
Jun-17-21 Initiated
Citigroup
Buy
$75
May-14-21 Upgrade
CJS Securities
Market Perform → Market Outperform
Apr-20-21 Downgrade
Morgan Stanley
Overweight → Equal-Weight
Apr-19-21 Downgrade
CJS Securities
Market Outperform → Market Perform
Feb-03-21 Upgrade
Barrington Research
Mkt Perform → Outperform
$140
Jan-21-21 Downgrade
Barrington Research
Outperform → Mkt Perform
Nov-05-20 Upgrade
Barrington Research
Mkt Perform → Outperform
$106
May-06-20 Downgrade
Barrington Research
Outperform → Mkt Perform
Mar-31-20 Upgrade
CJS Securities
Market Perform → Market Outperform
Jan-10-20 Initiated
Needham
Buy
$138
Aug-07-19 Reiterated
Barrington Research
Outperform
$116 → $139
May-14-19 Upgrade
Raymond James
Mkt Perform → Outperform
$110
May-08-19 Reiterated
Barrington Research
Outperform
$112 → $116
Aug-09-18 Reiterated
Barrington Research
Outperform
$90 → $118
Feb-07-18 Reiterated
Barrington Research
Outperform
$57 → $71
Show Previous Ratings
Jun-14-24 09:40AM
Jun-13-24 10:19AM
Jun-03-24 09:45AM
May-30-24 02:41AM
02:41AM
09:40AM
Loading…
May-29-24 09:40AM
May-27-24 12:45PM
May-24-24 09:55AM
May-23-24 12:00PM
06:00AM
May-22-24 09:13AM
02:06AM
May-21-24 04:05PM
May-17-24 12:00PM
10:20AM
09:15AM
Loading…
May-14-24 09:15AM
May-13-24 09:40AM
May-10-24 03:57PM
12:41PM
10:53AM
10:37AM
May-09-24 10:55AM
09:30AM
07:20AM
06:39AM
06:28AM
(Associated Press Finance)
06:00AM
May-08-24 09:15PM
May-06-24 09:16AM
May-01-24 11:51AM
09:03AM
Loading…
Apr-12-24 09:03AM
Apr-10-24 04:58PM
Apr-08-24 03:20PM
Apr-05-24 09:48AM
Apr-04-24 06:30AM
Apr-01-24 08:00AM
Mar-29-24 09:30AM
Mar-11-24 09:30AM
Mar-06-24 06:54AM
Mar-05-24 06:18AM
06:00AM
Feb-27-24 12:00PM
Feb-21-24 05:57PM
05:55PM
Feb-18-24 01:26PM
Feb-09-24 10:39AM
10:34AM
09:40AM
Feb-08-24 10:00PM
(Thomson Reuters StreetEvents)
09:30AM
07:10AM
06:33AM
06:10AM
(Associated Press Finance)
06:00AM
Feb-05-24 09:16AM
Feb-01-24 10:00AM
Jan-31-24 12:45PM
Jan-18-24 09:40AM
Jan-12-24 09:45AM
Jan-11-24 04:05PM
Jan-03-24 01:56PM
Dec-29-23 12:34PM
Dec-25-23 09:30AM
09:30AM
Dec-18-23 09:45AM
Dec-15-23 12:45PM
Dec-12-23 06:00AM
Dec-07-23 04:05PM
Dec-05-23 09:40AM
Dec-04-23 12:09PM
Nov-30-23 09:35AM
Nov-28-23 12:45PM
Nov-27-23 12:39PM
10:46AM
Nov-23-23 09:45AM
Nov-10-23 12:45PM
Nov-06-23 09:45AM
Nov-05-23 02:30PM
Nov-03-23 10:31AM
Nov-02-23 09:30AM
07:34AM
07:00AM
06:18AM
(Associated Press Finance)
06:00AM
Nov-01-23 06:27PM
Oct-26-23 10:02AM
Oct-20-23 12:45PM
09:40AM
Oct-19-23 11:49AM
Oct-18-23 11:10AM
11:05AM
Oct-17-23 11:17AM
08:33AM
Oct-16-23 08:28AM
Oct-13-23 10:05AM
08:28AM
Oct-12-23 12:04PM
11:58AM
08:33AM
08:14AM
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Simon, Christopher President & CEO Jun 06 '24 Option Exercise 41.64 104,516 4,352,046 433,877 Jun 07 04:15 PM Basil Michelle L EVP and General Counsel May 29 '24 Sale 88.08 12,990 1,144,208 31,257 May 29 05:38 PM Strong Stewart W President, Global Hospital May 29 '24 Sale 87.53 8,857 775,253 18,196 May 29 05:27 PM Strong Stewart W President, Global Hospital May 20 '24 Option Exercise 56.57 2,241 126,773 20,437 May 21 06:01 PM Basil Michelle L EVP and General Counsel May 20 '24 Sale 95.08 1,604 152,508 31,257 May 21 05:46 PM Llorens Josep EVP, Global Manufacturing May 20 '24 Sale 95.08 987 93,844 21,310 May 21 05:52 PM Strong Stewart W President, Global Hospital May 20 '24 Sale 95.11 686 65,245 18,196 May 21 06:01 PM Basil Michelle L EVP and General Counsel May 17 '24 Sale 95.00 1,073 101,935 29,352 May 21 05:46 PM Llorens Josep EVP, Global Manufacturing May 17 '24 Sale 94.82 822 77,942 16,350 May 21 05:52 PM Strong Stewart W President, Global Hospital May 16 '24 Option Exercise 57.60 2,410 138,816 18,018 May 17 05:11 PM Basil Michelle L EVP and General Counsel May 16 '24 Sale 96.14 985 94,698 30,425 May 17 05:02 PM Llorens Josep EVP, Global Manufacturing May 16 '24 Sale 96.14 770 74,028 17,172 May 17 04:55 PM Strong Stewart W President, Global Hospital May 16 '24 Sale 96.04 733 70,397 15,608 May 17 05:11 PM Lingamneni Anila EVP, Chief Technology Officer May 06 '24 Sale 95.00 2,305 218,975 12,295 May 08 04:21 PM Strong Stewart W President, Global Hospital Sep 12 '23 Sale 90.65 228 20,668 16,221 Sep 13 04:19 PM Lingamneni Anila EVP, Chief Technology Officer Sep 11 '23 Sale 90.00 2,305 207,450 14,495 Sep 13 04:20 PM Dockendorff Charles J Director Sep 05 '23 Sale 87.68 10,215 895,651 2,226 Sep 07 04:23 PM Llorens Josep EVP, Global Manufacturing Jul 18 '23 Option Exercise 57.10 4,928 281,390 23,391 Jul 20 04:17 PM Llorens Josep EVP, Global Manufacturing Jul 18 '23 Sale 90.00 4,928 443,520 18,463 Jul 20 04:17 PM Simon, Christopher President & CEO Jun 29 '23 Option Exercise 28.61 196,746 5,629,887 414,113 Jun 30 04:17 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite